Kevin Charles Gorman
Director · 2 filings · Latest: May 27, 2026
NEUROCRINE BIOSCIENCES INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|
NBIX | Kevin Charles Gorman | Director | May 19, 2026 | Sale | $154.33 | 245,088 | $37.8M | 511,293 | |
NBIX | Kevin Charles Gorman | Director | May 19, 2026 | Option Exercise | $43.24 | 205,088 | $8.9M | 756,381 | |